Skip to main content
. 2016 Dec 13;6:1–7. doi: 10.1016/j.jctube.2016.12.001

Table 1.

Study quality assessment of the ten studies included in the systematic review.

Main author, publication year (reference) Patient sampling
Definition of delay*
Definition of confirmation of TB diagnosis
Dealing with confounding
Consecutive or random (low risk of bias) Not consecutive or random (high risk of bias) Not described (no description) Clearly stated delay definition (low risk of bias) Stated but delay definition unclear (high risk of bias) No definition (no description) Clearly stated method of Dx of TB (low risk of bias) No definition (no description) Potential confounders identified and adjusted for (low risk of bias) Potential confounders not identified, or identified but not adjusted for (high risk of bias)
Rush 2016 [11] All cases included Clearly stated Culture or PCR Confounders identified but not adjusted for
Wang 2015 [12] All cases included Clearly stated 50–60% by culture or NAAT; rest by ICD code Confounders identified but not adjusted for
Kim 2013 [13] Not described Clearly stated Culture Confounders identified but not adjusted for
Wang 2011 [14] All cases included Clearly stated Culture Confounders identified but not adjusted for
Jeon 2011 [15] Not described Clearly stated Culture Confounders identified but not adjusted for
Wang 2006 [16] All cases included Clearly stated Culture Yes, adjusted for smear status
Sierros 2006 [17] All cases included; some cases later excluded re: availability of medical records or results Clearly stated Culture Yes, adjusted for smear status
Golub 2005 [18] All cases eligible but sampling strategy not described Clearly stated Culture Confounders identified but not adjusted for
Yoon 2005 [19] Not described Clearly stated Culture Confounders identified but not adjusted for
Dooley 2002 [20] All cases included Clearly stated Culture Yes, adjusted for smear status
*

The definition of delay varied between the studies: time of sputum collection to initiation of anti-TB medications: 2 studies; presentation to initiation of anti-TB medications: 5 studies; time of initiation of antibiotics to initiation of anti-TB medications: 2 studies; time of sputum collection to culture growth: 1 study